Search results

From Proteopedia

Jump to: navigation, search

There is no page with the exact title "Inhibitory_Concentration_.28IC50.29". The search results for "Inhibitory_Concentration_.28IC50.29" are displayed below. You can create a page titled Inhibitory_Concentration_.28IC50.29 (by clicking on the red link).

For more information about searching Proteopedia, see Help.

Showing below 10 results starting with #1.


View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)

No page title matches

Page text matches

  1. Statin Pharmacokinetics (1,335 bytes)
    29: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    31: ! 19-29
    45: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    53: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    61: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
  2. ACE Inhibitor Pharmacokinetics (1,339 bytes)
    32: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    50: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    59: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    68: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
  3. Tositumomab (1,231 bytes)
    24: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    30: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    36: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    38: ! 32939000
    42: ! [[Pharmacokinetics#Clearance_.28Cl.29|Clearance]] (L/h)
  4. Dipeptidyl Peptidase-4 Inhibitor Pharmacokinetics (1,251 bytes)
    16: ! 290
    20: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    30: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    35: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    40: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
  5. Bevacizumab (2,325 bytes)
    30: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    33: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (days)
    36: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ug/ml/hr)
    39: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
    42: ! [[Pharmacokinetics#Clearance_.28Cl.29|Clearance]] (L/h)
  6. Sunitinib (3,575 bytes)
    13: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] for Sunitinib is 40nM for inact...
  7. NSAID Pharmacokinetics (3,873 bytes)
    56: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    90: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    107: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    124: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] COX-1 (nM) in Whole Blood
    133: ! 2900
  8. Acetylcholinesterase Inhibitor Pharmacokinetics (1,187 bytes)
    20: ! 29.3
    23: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    35: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    41: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    47: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
  9. Glitazone Pharmacokinetics (998 bytes)
    19: ! [[Pharmacokinetics#Bioavailability_.28F.29|Bioavailability]] (%)
    27: ! [[Pharmacokinetics#Half_Life_.28T1.2F2.29|T<sub>1/2</sub>]] (hr)
    31: ! [[Pharmacokinetics#Area_Under_the_Curve_.28AUC.29|AUC]] (ng/ml/hr)
    35: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]] (nM)
  10. Sitagliptin (3,135 bytes)
    12: ...Pharmacokinetics#Inhibitory_Concentration_.28IC50.29|IC<sub>50</sub>]]: 18 nM vs. >50,000 nM for other...

View (previous 20) (next 20) (20 | 50 | 100 | 250 | 500)



Search in namespaces:

List redirects
Search for
Views
Personal tools